{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some embodiments, the AB has a dissociation constant of about 100 nM or less for binding to CD166.\nIn some embodiments, the AB has a dissociation constant of about 10 nM or less for binding to mammalian CD166.\nIn some embodiments, the AB has a dissociation constant of about 5 nM or less for binding to CD166.\nIn some embodiments, the AB has a dissociation constant of about 1 nM or less for binding to CD166.\nIn some embodiments, the AB has a dissociation constant of about 0.5 nM or less for binding to CD166.\nIn some embodiments, the AB has a dissociation constant of about 0.1 nM or less for binding to CD166.\nIn some embodiments, the AB has a dissociation constant of 0.01 nM to 100 nM, 0.01 nM to 10 nM, 0.01 nM to 5 nM, 0.01 nM to 1 nM, 0.01 to 0.5 nM, 0.01 nm to 0.1 nM, 0.01 nm to 0.05 nM, 0.05 nM to 100 nM, 0.05 nM to 10 nM, 0.05 nM to 5 nM, 0.05 nM to 1 nM, 0.05 to 0.5 nM, 0.05 nm to 0.1 nM, 0.1 nM to 100 nM, 0.1 nM to 10 nM, 0.1 nM to 5 nM, 0.1 nM to 1 nM, 0.1 to 0.5 nM, 0.5 nM to 100 nM, 0.5 nM to 10 nM, 0.5 nM to 5 nM, 0.5 nM to 1 nM, 1 nM to 100 nM, 1 nM to 10 nM, 1 nM to 5 nM, 5 nM to 100 nM, 5 nM to 10 nM, or 10 nM to 100 nM, for binding to mammalian CD166.\nIn some embodiments, the activatable antibody in an uncleaved state specifically binds to mammalian CD166 with a dissociation constant less than or equal to 1 nM, less than or equal to 5 nM, less than or equal to 10 nM, less than or equal to 15 nM, less than or equal to 20 nM, less than or equal to 25 nM, less than or equal to 50 nM, less than or equal to 100 nM, less than or equal to 150 nM, less than or equal to 250 nM, less than or equal to 500 nM, less than or equal to 750 nM, less than or equal to 1000 nM, and 122/or less than or equal to 2000 nM.\nIn some embodiments, the activatable antibody in an uncleaved state specifically binds to mammalian CD166 with a dissociation constant greater than or equal to 1 nM, greater than or equal to 5 nM, greater than or equal to 10 nM, greater than or equal to 15 nM, greater than or equal to 20 nM, greater than or equal to 25 nM, greater than or equal to 50 nM, greater than or equal to 100 nM, greater than or equal to 150 nM, greater than or equal to 250 nM, greater than or equal to 500 nM, greater than or equal to 750 nM, greater than or equal to 1000 nM, and 122/or greater than or equal to 2000 nM.\nIn some embodiments, the activatable antibody in an uncleaved state specifically binds to the mammalian CD166 with a dissociation constant in the range of 1 nM to 2000 nM, 1 nM to 1000 nM, 1 nM to 750 nM, 1 nM to 500 nM, 1 nM to 250 nM, 1 nM to 150 nM, 1 nM to 100 nM, 1 nM to 50 nM, 1 nM to 25 nM, 1 nM to 15 nM, 1 nM to 10 nM, 1 nM to 5 nM, 5 nM to 2000 nM, 5 nM to 1000 nM, 5 nM to 750 nM, 5 nM to 500 nM, 5 nM to 250 nM, 5 nM to 150 nM, 5 nM to 100 nM, 5 nM to 50 nM, 5 nM to 25 nM, 5 nM to 15 nM, 5 nM to 10 nM, 10 nM to 2000 nM, 10 nM to 1000 nM, 10 nM to 750 nM, 10 nM to 500 nM, 10 nM to 250 nM, 10 nM to 150 nM, 10 nM to 100 nM, 10 nM to 50 nM, 10 nM to 25 nM, 10 nM to 15 nM, 15 nM to 2000 nM, 15 nM to 1000 nM, 15 nM to 750 nM, 15 nM to 500 nM, 15 nM to 250 nM, 15 nM to 150 nM, 15 nM to 100 nM, 15 nM to 50 nM, 15 nM to 25 nM, 25 nM to 2000 nM, 25 nM to 1000 nM, 25 nM to 750 nM, 25 nM to 500 nM, 25 nM to 250 nM, 25 nM to 150 nM, 25 nM to 100 nM, 25 nM to 50 nM, 50 nM to 2000 nM, 50 nM to 1000 nM, 50 nM to 750 nM, 50 nM to 500 nM, 50 nM to 250 nM, 50 nM to 150 nM, 50 nM to 100 nM, 100 nM to 2000 nM, 100 nM to 1000 nM, 100 nM to 750 nM, 100 nM to 500 nM, 100 nM to 250 nM, 100 nM to 150 nM, 150 nM to 2000 nM, 150 nM to 1000 nM, 150 nM to 750 nM, 150 nM to 500 nM, 150 nM to 250 nM, 250 nM to 2000 nM, 250 nM to 1000 nM, 250 nM to 750 nM, 250 nM to 500 nM, 500 nM to 2000 nM, 500 nM to 1000 nM, 500 nM to 750 nM, 500 nM to 500 nM, 500 nM to 250 nM, 500 nM to 150 nM, 500 nM to 100 nM, 500 nM to 50 nM, 750 nM to 2000 nM, 750 nM to 1000 nM, or 1000 nM to 2000 nM.\nIn some embodiments, the activatable antibody in an activated state specifically binds to mammalian CD166 with a dissociation constant is less than or equal to 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, 1 nM, 5 nM, or 10 nM.\nIn some embodiments, the activatable antibody in an activated state specifically binds to mammalian CD166 with a dissociation constant is greater than or equal to 0.01 nM, 0.05 nM, 0.1 nM, 0.5 nM, 1 nM, 5 nM, or 10 nM.\nIn some embodiments, the activatable antibody in an activated state specifically binds to the mammalian CD166 with a dissociation constant in the range of 0.01 nM to 100 nM, 0.01 nM to 10 nM, 0.01 nM to 5 nM, 0.01 nM to 1 nM, 0.01 to 0.5 nM, 0.01 nm to 0.1 nM, 0.01 nm to 0.05 nM, 0.05 nM to 100 nM, 0.05 nM to 10 nM, 0.05 nM to 5 nM, 0.05 nM to 1 nM, 0.05 to 0.5 nM, 0.05 nm to 0.1 nM, 0.1 nM to 100 nM, 0.1 nM to 10 nM, 0.1 nM to 5 nM, 0.1 nM to 1 nM, 0.1 to 0.5 nM, 0.5 nM to 100 nM, 0.5 nM to 10 nM, 0.5 nM to 5 nM, 0.5 nM to 1 nM, 1 nM to 100 nM, 1 nM to 10 nM, 1 nM to 5 nM, 5 nM to 100 nM, 5 nM to 10 nM, or 10 nM to 100 nM.\nIn some embodiments, the AB specifically binds to human CD166 or cynomolgus monkey CD166 with a dissociation constant of less than 1 nM.\nIn some embodiments, the AB blocks the ability of a natural ligand or receptor to bind to the mammalian CD166 with an EC50 less than or equal to 5 nM, less than or equal to 10 nM, less than or equal to 50 nM, less than or equal to 100 nM, less than or equal to 500 nM, and/or less than or equal to 1000 nM.\nIn some embodiments, the AB blocks the ability of mammalian CD6 to bind to the mammalian CD166 with an EC50 less than or equal to 5 nM, less than or equal to 10 nM, less than or equal to 50 nM, less than or equal to 100 nM, less than or equal to 500 nM, and/or less than or equal to 1000 nM.\nIn some embodiments, the AB blocks the ability of a natural ligand to bind to the mammalian CD166 with an EC50 of 5 nM to 1000 nM, 5 nM to 500 nM, 5 nM to 100 nM 5 nM to 50 nM, 5 nM to 10 nM, 10 nM to 1000 nM, 10 nM to 500 nM, 10 nM to 100 nM 10 nM to 50 nM, 50 nM to 1000 nM, 50 nM to 500 nM, 50 nM to 100 nM, 100 nM to 1000 nM, 100 nM to 500 nM, 500 nM to 1000 nM."}
{"raw_mentions": "In some embodiments, the dissociation constant (Kd) of the MM towards the AB is no more than 2, 3, 4, 5, 10, 25, 50, 100, 250, 500, 1,000, 2,500, 5,000, 10,000, 50,000, 100,000, 500,000, 1,000,000, 5,000,000, 10,000,000, 50,000,000 times or greater, or between 1-5, 5-10, 10-100, 10-1,000, 10-10,000, 10-100,000, 10-1,000,000, 10-10,000,000, 100-1,000, 100-10,000, 100-100,000, 100-1,000,000, 100-10,000,000, 1,000-10,000, 1,000-100,000, 1,000-1,000,000, 1000-10,000,000, 10,000-100,000, 10,000-1,000,000, 10,000-10,000,000, 100,000-1,000,000, or 100,000-10,000,000 times or greater than the dissociation constant of the AB towards the target.\nIn some embodiments, the coupling of the MM to the AB reduces the ability of the AB to bind CD166 such that the dissociation constant (Kd) of the AB when coupled to the MM towards CD166 is at least two times greater than the Kd of the AB when not coupled to the MM towards CD166.\nIn some embodiments, the coupling of the MM to the AB reduces the ability of the AB to bind CD166 such that the dissociation constant (Kd) of the AB when coupled to the MM towards CD166 is at least five times greater than the Kd of the AB when not coupled to the MM towards CD166.\nIn some embodiments, the coupling of the MM to the AB reduces the ability of the AB to bind CD166 such that the dissociation constant (Kd) of the AB when coupled to the MM towards CD166 is at least 10 times greater than the Kd of the AB when not coupled to the MM towards CD166.\nIn some embodiments, the coupling of the MM to the AB reduces the ability of the AB to bind CD166 such that the dissociation constant (Kd) of the AB when coupled to the MM towards CD166 is at least 20 times greater than the Kd of the AB when not coupled to the MM towards CD166.\nIn some embodiments, the coupling of the MM to the AB reduces the ability of the AB to bind CD166 such that the dissociation constant (Kd) of the AB when coupled to the MM towards CD166 is at least 40 times greater than the Kd of the AB when not coupled to the MM towards CD166.\nIn some embodiments, the coupling of the MM to the AB reduces the ability of the AB to bind CD166 such that the dissociation constant (Kd) of the AB when coupled to the MM towards CD166 is at least 100 times greater than the Kd of the AB when not coupled to the MM towards CD166.\nIn some embodiments, the coupling of the MM to the AB reduces the ability of the AB to bind CD166 such that the dissociation constant (Kd) of the AB when coupled to the MM towards CD166 is at least 1000 times greater than the Kd of the AB when not coupled to the MM towards CD166.\nIn some embodiments, the coupling of the MM to the AB reduces the ability of the AB to bind CD166 such that the dissociation constant (Kd) of the AB when coupled to the MM towards CD166 is at least 10,000 times greater than the Kd of the AB when not coupled to the MM towards CD166.\nIn some embodiments, the CM is positioned in the activatable antibody such that when the activatable antibody is in the uncleaved state, binding of the activatable antibody to CD166 is reduced to occur with a dissociation constant that is at least twofold greater than the dissociation constant of an unmodified AB binding to CD166, whereas in the cleaved state (i.e., when the activatable antibody is in the cleaved state), the AB binds CD166.\nIn some embodiments, the CM is positioned in the activatable antibody such that when the activatable antibody is in the uncleaved state, binding of the activatable antibody to CD166 is reduced to occur with a dissociation constant that is at least fivefold greater than the dissociation constant of an unmodified AB binding to CD166, whereas in the cleaved state (i.e., when the activatable antibody is in the cleaved state), the AB binds CD166.\nIn some embodiments, the CM is positioned in the activatable antibody such that when the activatable antibody is in the uncleaved state, binding of the activatable antibody to CD166 is reduced to occur with a dissociation constant that is at least 10-fold greater than the dissociation constant of an unmodified AB binding to CD166, whereas in the cleaved state (i.e., when the activatable antibody is in the cleaved state), the AB binds CD166.\nIn some embodiments, the CM is positioned in the activatable antibody such that when the activatable antibody is in the uncleaved state, binding of the activatable antibody to CD166 is reduced to occur with a dissociation constant that is at least 20-fold greater than the dissociation constant of an unmodified AB binding to CD166, whereas in the cleaved state (i.e., when the activatable antibody is in the cleaved state), the AB binds CD166.\nIn some embodiments, the CM is positioned in the activatable antibody such that when the activatable antibody is in the uncleaved state, binding of the activatable antibody to CD166 is reduced to occur with a dissociation constant that is at least 40-fold greater than the dissociation constant of an unmodified AB binding to CD166, whereas in the cleaved state, the AB binds CD166.\nIn some embodiments, the CM is positioned in the activatable antibody such that when the activatable antibody is in the uncleaved state, binding of the activatable antibody to CD166 is reduced to occur with a dissociation constant that is at least 50-fold greater than the dissociation constant of an unmodified AB binding to CD166, whereas in the cleaved state, the AB binds CD166.\nIn some embodiments, the CM is positioned in the activatable antibody such that when the activatable antibody is in the uncleaved state, binding of the activatable antibody to CD166 is reduced to occur with a dissociation constant that is at least 100-fold greater than the dissociation constant of an unmodified AB binding to CD166, whereas in the cleaved state, the AB binds CD166.\nIn some embodiments, the CM is positioned in the activatable antibody such that when the activatable antibody is in the uncleaved state, binding of the activatable antibody to CD166 is reduced to occur with a dissociation constant that is at least 200-fold greater than the dissociation constant of an unmodified AB binding to CD166, whereas in the cleaved state, the AB binds CD166."}
{"final_json": [{"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "2", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "3", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "4", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "5", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "10", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "25", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "50", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "100", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "250", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "500", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "1,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "2,500", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "5,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "10,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "50,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "100,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "500,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "1,000,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "5,000,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "10,000,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "50,000,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "AB", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "2", "unit": "times", "is_logarithmic": false}, {"molecule_name": "AB", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "5", "unit": "times", "is_logarithmic": false}, {"molecule_name": "AB", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "10", "unit": "times", "is_logarithmic": false}, {"molecule_name": "AB", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "20", "unit": "times", "is_logarithmic": false}, {"molecule_name": "AB", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "40", "unit": "times", "is_logarithmic": false}, {"molecule_name": "AB", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "100", "unit": "times", "is_logarithmic": false}, {"molecule_name": "AB", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "1000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "AB", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "10,000", "unit": "times", "is_logarithmic": false}, {"molecule_name": "activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "2", "unit": "fold", "is_logarithmic": false}, {"molecule_name": "activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "5", "unit": "fold", "is_logarithmic": false}, {"molecule_name": "activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "10", "unit": "fold", "is_logarithmic": false}, {"molecule_name": "activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "20", "unit": "fold", "is_logarithmic": false}, {"molecule_name": "activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "40", "unit": "fold", "is_logarithmic": false}, {"molecule_name": "activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "50", "unit": "fold", "is_logarithmic": false}, {"molecule_name": "activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "100", "unit": "fold", "is_logarithmic": false}, {"molecule_name": "activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "200", "unit": "fold", "is_logarithmic": false}]}
{"raw_mentions": "The Kd of the AB modified with a MM towards the target is at least 5, 10, 25, 50, 100, 250, 500, 1,000, 2,500, 5,000, 10,000, 50,000, 100,000, 500,000, 1,000,000, 5,000,000, 10,000,000, 50,000,000 or greater, or between 5-10, 10-100, 10-1,000, 10-10,000, 10-100,000, 10-1,000,000, 10-10,000,000, 100-1,000, 100-10,000, 100-100,000, 100-1,000,000, 100-10,000,000, 1,000-10,000, 1,000-100,000, 1,000-1,000,000, 1000-10,000,000, 10,000-100,000, 10,000-1,000,000, 10,000-10,000,000, 100,000-1,000,000, or 100,000-10,000,000 times greater than the Kd of the AB not modified with an MM or of the parental AB towards the target.\nThe dissociation constant (Kd) of the MM towards the AB is generally greater than the Kd of the AB towards the target.\nThe Kd of the MM towards the AB can be at least 5, 10, 25, 50, 100, 250, 500, 1,000, 2,500, 5,000, 10,000, 100,000, 1,000,000 or even 10,000,000 times greater than the Kd of the AB towards the target.\nIn some embodiments, the dissociation constant (Kd) of the MM towards the AB is approximately equal to the Kd of the AB towards the target.\nIn some embodiments, the dissociation constant (Kd) of the MM towards the AB is no more than the dissociation constant of the AB towards the target.\nIn some embodiments, the dissociation constant (Kd) of the MM towards the AB is less than the dissociation constant of the AB towards the target.\nIn some embodiments, the dissociation constant (Kd) of the MM towards the AB is greater than the dissociation constant of the AB towards the target.\nIn some embodiments, the MM has a Kd for binding to the AB that is no more than the Kd for binding of the AB to the target.\nIn some embodiments, the MM has a Kd for binding to the AB that is no less than the Kd for binding of the AB to the target.\nIn some embodiments, the MM has a Kd for binding to the AB that is approximately equal to the Kd for binding of the AB to the target.\nIn some embodiments, the MM has a Kd for binding to the AB that is less than the Kd for binding of the AB to the target.\nIn some embodiments, the MM has a Kd for binding to the AB that is greater than the Kd for binding of the AB to the target.\nIn some embodiments, the MM has a Kd for binding to the AB that is no more than 2, 3, 4, 5, 10, 25, 50, 100, 250, 500, or 1,000 fold greater than the Kd for binding of the AB to the target."}
{"final_json": [{"molecule_name": "AB modified with a MM", "protein_target_name": "target", "binding_metric": "Kd", "value": ">5", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": ">=5", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "approximately equal", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "no more than", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "<", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": ">", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "no more than", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "no less than", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "approximately equal", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "<", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": ">", "unit": null, "is_logarithmic": false}, {"molecule_name": "MM", "protein_target_name": "AB", "binding_metric": "Kd", "value": "no more than 2, 3, 4, 5, 10, 25, 50, 100, 250, 500, or 1,000 fold greater", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics with numeric values, and units. It appears to be a general description of activatable antibodies and their design."}
{"raw_mentions": "An antibody is said to specifically bind an antigen when the dissociation constant is \u22641 \u03bcM; in some embodiments, \u2264100 nM and in some embodiments, \u226410 nM.\nAn antibody of the present disclosure is said to specifically bind to the target, when the binding constant (Kd) is \u22641 \u03bcM, in some embodiments \u2264100 nM, in some embodiments \u226410 nM, and in some embodiments \u2264100 pM to about 1 pM, as measured by assays such as radioligand binding assays or similar assays known to those skilled in the art."}
{"final_json": [{"molecule_name": "antibody", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "\u22641", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "\u2264100", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": "antigen", "binding_metric": "Kd", "value": "\u226410", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": "target", "binding_metric": "Kd", "value": "\u22641", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": "target", "binding_metric": "Kd", "value": "\u2264100", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": "target", "binding_metric": "Kd", "value": "\u226410", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": "target", "binding_metric": "Kd", "value": "\u2264100", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "antibody", "protein_target_name": "target", "binding_metric": "Kd", "value": "about 1", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nCD166 M9 vk1/HcB, 4.4 nM, 1\nCD166-16522-2001, 423.7 nM, 95\nCD166-7614-2001, 998.6 nM, 225\nCD166-7614.5-2001, 495.0 nM, 112\nCD166-7614.6-2001, 265.6 nM, 60\nCD166-7614.7-2001, 618.6 nM, 139\nCD166-7614.8-2001, 82.2 nM, 19\nCD166-7614.9-2001, 534.0 nM, 120\nCD166-7614.10-2001, 685.2 nM, 154\nCD166-7614.11-2001, 544.0 nM, 123\nCD166-7614.12-2001, 331.9 nM, 75\nCD166-7614.13-2001, 77.7 nM, 18\nCD166-16522.14-2001, 422.1 nM, 95\nCD166-16522.15-2001, 447.7 nM, 101"}
{"final_json": [{"molecule_name": "CD166 M9 vk1/HcB", "protein_target_name": null, "binding_metric": "IC50", "value": "4.4", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-16522-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "423.7", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "998.6", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.5-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "495.0", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.6-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "265.6", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.7-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "618.6", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.8-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "82.2", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.9-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "534.0", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.10-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "685.2", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.11-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "544.0", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.12-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "331.9", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-7614.13-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "77.7", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-16522.14-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "422.1", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "CD166-16522.15-2001", "protein_target_name": null, "binding_metric": "IC50", "value": "447.7", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences:\n\nUnder these conditions, apparent exemplary binding affinities (Kd) by ELISA are 96.2 nM and 1.3 nM for the anti-CD166 activatable antibody and the anti-CD166 antibody of the present disclosure, respectively.\nIn the exemplary HCC1806 cell binding assay as measured by flow cytometry, apparent binding affinities (Kd) are 372 nM and 3.2 nM for the anti-CD166 activatable antibody and the anti-CD166 antibody of the present disclosure, respectively."}
{"final_json": [{"molecule_name": "anti-CD166 activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "96.2", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD166 antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "1.3", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD166 activatable antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "372", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD166 antibody", "protein_target_name": "CD166", "binding_metric": "Kd", "value": "3.2", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics, numeric values, and units that are required to be extracted. The text primarily describes methods, calculations, and experimental procedures, but does not provide specific data that includes all four required components."}
{"raw_mentions": "As shown in <figref idrefs=\"DRAWINGS\">FIG. <b>17</b></figref>, an anti-CD166 antibody of the present disclosure bound to human and cynomolgus cells with comparable affinity (EC<sub>50 </sub>of 3.1 nM to human cells, and EC<sub>50 </sub>of 1.7 nM to cynomolgus cells).\nIn this exemplary assay, the anti-CD166 antibody of the present disclosure and MAB656 showed similar levels of inhibition of cell adhesion to CD6. Both antibodies showed nearly an EC50 of approximately 3.7 nM."}
{"final_json": [{"molecule_name": "anti-CD166 antibody", "protein_target_name": "CD166", "binding_metric": "EC50", "value": "3.1", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD166 antibody", "protein_target_name": "CD166", "binding_metric": "EC50", "value": "1.7", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD166 antibody", "protein_target_name": "CD6", "binding_metric": "EC50", "value": "3.7", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "MAB656", "protein_target_name": "CD6", "binding_metric": "EC50", "value": "3.7", "unit": "nM", "is_logarithmic": false}]}
